Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06712979Not ApplicableNot Yet Recruiting

Addiction of Lung Volume Recruitment Technique in Lee Silverman Protocol for Voice Professionals

Role: lead

NCT04595097Not ApplicableCompleted

Inspiratory Muscle Training in COVID-19 Patients

Role: lead

NCT04226144Not ApplicableTerminated

Breath Stacking Technique Associated With Expiratory Muscle Training in Amyotrophic Lateral Sclerosis Patients

Role: lead

NCT04382378Not ApplicableUnknown

Effects of NMES in Critically Ill Patients

Role: lead

All 4 trials loaded